Survey results show level of concordance between patients with CRC and their caregivers when rating care quality. The survey also measured whether clinical or demographic factors influenced the agreement between patient-caregiver pairs.
According to this prospective study, the lifetime risk of cancer in men with a pathogenic germline MSH6 alteration is relatively low.
Young colorectal cancer patients more often present via emergency; have lowest percentage early-stage cancer.
The combination of ENCO and BINI had greater antitumor activity against mCRC cells with the BRAF V600E mutation.
In this study, preexisting immunity to the viral vector used for the vaccine led to poor responses, as the product was neutralized.
Younger adults presenting with colorectal cancer present with more advanced disease than older adults.
Early results from the Polish II study showed a significant improvement in OS for preoperative short-course RT/chemotherapy compared with long-term chemo-RT.
New research has linked microsatellite instability and the number of insertion/deletion mutations present in a tumor to clinical response to checkpoint inhibition.
The incidence of early onset colorectal cancer per 100,000 people increased from 6.7 during 1995-1996 to 11.5 during 2014-2015 for residents of the state of WA.
The reintroduction of FOLFOXIRI/bev in the progressive setting may provide a further benefit in mCRC.
